Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin–rifampicin combination therapy in an intensive care unit
- 6 December 2005
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 25 (1), 61-62
- https://doi.org/10.1007/s10096-005-0063-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Molecular fingerprinting of fusidic acid- and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitalsJournal of Medical Microbiology, 2002
- Rapid Molecular Typing of Methicillin-ResistantStaphylococcus aureusby PCR-RFLPInfection Control & Hospital Epidemiology, 2001
- Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1986
- The use of rifampicin in staphylococcal infections - a reviewJournal of Antimicrobial Chemotherapy, 1984
- Use of Rifampin for the Treatment of Serious Staphylococcal and Gram-Negative Bacillary InfectionsClinical Infectious Diseases, 1983
- In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1983